Form 4 for INBX Inhibrx Biosciences, Inc.
Accepted 2025-03-28 00:00:00 ET · period of report 2025-03-27 · accession 0002007919-25-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-03-28 | 2025-03-27 | INBX | Kayyem Jon Faiz | Dir | G - Gift | $0.00 | -90.0K | 419.4K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-27 | G | D | 90,000 | $0.00 | 419,360 | I By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | — | — | (F2) These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein. |